Europe Drug Delivery Market Witnessed a Robust Expansion of US$ 536.1 Billion at a CAGR of 7.3% till 2024
Request for Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-drug-delivery-devices-market
Major Market Drivers and Restraints:
• Growing Industry-Academia Collaborations
• Increasing R&D activities and expenditure
• Quality concerns
• Technological developments
• Increasing funding for proteomics research and drug discovery
The Europe drug delivery market is segmented on the basis of product type, technology, components, delivery mode, end-user, and geography.
Browse Full Report @ http://databridgemarketresearch.com/reports/europe-drug-delivery-devices-market/
On the basis of route of administration the Europe drug delivery market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug. The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups. Based on the route of administration, oral drug delivery market dominates the market in 2016 with 44.5% market share. Injectable drug delivery market is considered to be the fastest growing market with the CAGR of 11.7%.
Request for TOC: http://databridgemarketresearch.com/toc/?dbmr=europe-drug-delivery-devices-market
Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes. The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable.
The Europe pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
The Europe ocular drug delivery is segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.
The Europe Nasal drug delivery devices are segmented on the basis of product type into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented on the basis of product form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sublingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of end users the Europe drug delivery market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. In 2016, the hospitals segment dominates the Europe drug delivery market with more than 60.6% market share.
Based on geography the market is segmented into 11 countries, Germany, France, U.K., Spain, Italy, Russia, Netherlands, Switzerland, Turkey, Belgium, and Rest of Europe. Germany is expected to dominate the market with largest share of 23.6% in 2016. However the drug delivery market in France is expected to be the fastest growing among the other countries in Europe.
The Europe Drug Delivery Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.
Some of the major players operating in this market are
• Bayer AG
• Johnson & Johnson
• Novartis AG
• Pfizer, Inc.
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc.
• Merck & Co.
• Antares Pharma
• Becton Dickinson and Company
• Biolase, Inc.
• Cima Labs, Inc.
• West Pharmaceuticals
• Antares Pharma
• Skyepharma AG
• Valeant Pharmaceuticals
• DSM Biomedical
• Catalent, Inc.
Inquiry before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-drug-delivery-devices-market
Global Drug Delivery Devices Market – Trends and Forecast to 2024
Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024
Report Access: http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Europe Drug Delivery Market Witnessed a Robust Expansion of US$ 536.1 Billion at a CAGR of 7.3% till 2024 here
News-ID: 744358 • Views: 304
More Releases from Data Bridge Market Research
Photo Rejuvenation Devices Market Report Leading Players are biolitec AG, Candel …
Photo Rejuvenation Devices Market analysis report puts across the idea of high level analysis of major market segments and identification of opportunities. This information not only aids businesses in taking sound and proficient decisions but also helps decide the advertising, promotion, marketing and sales strategy more gainfully. Additionally, estimation of strategic options, suggestions of winning action plans and support to make critical bottom-line decisions is also provided by experienced and
Pharmacogenetic Testing Market Shows Strong Growth by 2026 Leading Players : Son …
Pharmacogenetic Testing Market report covers many business strategies such as new product launches, expansions, agreements, partnerships, joint ventures, acquisitions, and others that help to amplify their footprints in the market. This global market report additionally encompasses predictions utilizing a practical arrangement of suspicions and techniques. Depending on client’s demand, huge amount of business, product and market related information has been brought together via this report that eventually helps businesses create
Automated Cell Cultures Market Research Report Trend to 2026 : Top Companies are …
Automated Cell Cultures Market research report aids accomplish the needs of businesses for which it analyses the market from top to bottom by considering plentiful parameters. A strong research methodology used here consists of data models that include market overview and guide, vendor positioning grid, market time line analysis, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. The Automated Cell
Clinical Trial Imaging Market Size to 2026 : Leading Players are BioTelemetry, I …
Global clinical trial imaging market is segmented into five notable segments which are basis of product & services, modality, application, end user and distribution channel. Clinical Trial Imaging Market is a proficient and comprehensive marketing report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. Nowadays, businesses get highly benefited with the different segments covered in the market research report which makes available better market
More Releases for Europe
Synthetic Biology Market – Europe
Synthetic Biology Market Europe is expected to reach USD XX Billion by 2026 from USD XX Billion in 2016 at a CAGR of XX% (Detailed analysis of the market CAGR is provided in the report). Synthetic biology has expanded into various interdisciplinary fields that may be defined as the combination of artificial design and engineering to produce biological systems, chemicals or living organisms. Synthetic biology is also used for improving applications
Europe Wooden Doors Market
Europe Wooden Doors Market https://www.qandqmarketresearch.com/reports/wooden-doors-market-78 This report studies the Wooden Doorsmarket status and outlook of Europe and major countries, from angles of players, countries, product types and end industries; this report analyzes the top players in Europe and major countries, and splits the Wooden Doors market by product type and applications/end industries. The global Wooden Doors market is valued at XX million USD in 2018 and is expected to reach XX million
Europe Radiotherapy Market
The Europe Radiotherapy Market research report consists of a primary and secondary research along with an in-depth analysis of the quantitative and qualitative aspects by the expert industry analysts and professionals, leading management bodies, to gain a profound insight of the industry as well as the industry performance. The Europe Radiotherapy Market report presents a lucid picture of the current industry landscape, including the historical and projected market size, based
Europe Business Assembly
The Europe Business Assembly (EBA) is an international corporation for the evolution and implementation of economic and social development. The company was established in April 2000 and its history shows a plethora of promising initiatives, creative growth and professional victories. EBA’s activity demonstrates the capabilities and power of professional partnership. The year 2000 saw the beginning and the foundation of EBA with the signing of the memorandum of cooperation and
Smartsourcing in Eastern Europe
In 2008 the outsourcing business of Eastern Europe was estimated at nearly $2 billion, representing just a tiny fraction of the global IT outsourcing market, estimated at about $386 billion. According to the Gartner Dataquest predictions, in the next four years Eastern Europe is expected to outstrip the rest of the offshore market concentrated mainly in the “classical” locations like India. By 2010 Eastern Europe’s IT outsourcing market share is
Home Control conquers Europe
European Home Control Summit attracts participation from leading International companies and organizations 29. February 2008 - Copenhagen/Frankfurt - The first European Wireless Home Control Summit on 9 April 2008, taking place parallel to Light + Building, features leading companies such as Merten, Horstmann, Danfoss, and market researcher Parks Associates as well as publicly funded organizations like the Danish Energy Saving Trust (DEST) presenting the newest trends, products and market strategies pertaining